Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Böger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|February 10, 2004
Ximelagatran for secondary prevention of venous thromboembolismCarsten Böger, Stephan Schroll, Stephan Holmer
The New England Journal of Medicine|December 6, 2003
Everolimus in cardiac-transplant recipientsBernhard Banas, Carsten Böger, Bernhard Krämer
Lancet (London, England)|March 28, 2003
The COOPERATE trialBernd Krüger, Carsten Böger, Mike Stubanus, et al.
Deutsche Medizinische Wochenschrift (1946)|August 4, 2022
[High patient unawareness for chronic kidney disease even in later stages - but why is it more frequent in women than in men?]Susanne Stolpe, Christian Scholz, Andreas Stang, et al.
Diagnostic and Prognostic Research|November 18, 2021
A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocolMariella Gregorich, Andreas Heinzel, Michael Kammer, et al.
JAMA Network Open|April 5, 2023
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney DiseaseMariella Gregorich, Michael Kammer, Andreas Heinzel, et al.
Plos One|March 24, 2017
A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general populationKonstantinos Voskarides, Charalambos Stefanou, Myrtani Pieri, et al.
Research Square|July 29, 2024
A Large-Scale Genome-Wide Study of Gene-Sleep Duration Interactions for Blood Pressure in 811,405 Individuals from Diverse PopulationsHeming Wang, Pavithra Nagarajan, Thomas Winkler, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|February 10, 2004
Ximelagatran for secondary prevention of venous thromboembolismCarsten Böger, Stephan Schroll, Stephan Holmer
The New England Journal of Medicine|December 6, 2003
Everolimus in cardiac-transplant recipientsBernhard Banas, Carsten Böger, Bernhard Krämer
Lancet (London, England)|March 28, 2003
The COOPERATE trialBernd Krüger, Carsten Böger, Mike Stubanus, et al.
Deutsche Medizinische Wochenschrift (1946)|August 4, 2022
[High patient unawareness for chronic kidney disease even in later stages - but why is it more frequent in women than in men?]Susanne Stolpe, Christian Scholz, Andreas Stang, et al.
Diagnostic and Prognostic Research|November 18, 2021
A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocolMariella Gregorich, Andreas Heinzel, Michael Kammer, et al.
JAMA Network Open|April 5, 2023
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney DiseaseMariella Gregorich, Michael Kammer, Andreas Heinzel, et al.
Plos One|March 24, 2017
A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general populationKonstantinos Voskarides, Charalambos Stefanou, Myrtani Pieri, et al.
Research Square|July 29, 2024
A Large-Scale Genome-Wide Study of Gene-Sleep Duration Interactions for Blood Pressure in 811,405 Individuals from Diverse PopulationsHeming Wang, Pavithra Nagarajan, Thomas Winkler, et al.
Pageof 1